| Phase 14 trials |
|
Phase 1
|
NCT07489482 |
Apr → Dec 2026 expected |
diabetes mellitus |
Jiangsu HengRui Medicine Co., Ltd. |
Recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT07032688 |
Aug 2025 → Mar 2027 expected |
type 2 diabetes mellitus |
Jiangsu HengRui Medicine Co., Ltd. |
Recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT07588906 |
Feb → Jul 2024 |
— |
Jiangsu HengRui Medicine Co., Ltd. |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT05996380 |
Jun 2023 → Jan 2024 |
type 2 diabetes mellitus |
Jiangsu HengRui Medicine Co., Ltd. |
Unknown
|
No outcome recorded
|
| Phase 23 trials |
|
Phase 2
|
NCT07472725 |
Apr → Dec 2026 expected |
type 2 diabetes mellitus |
Jiangsu HengRui Medicine Co., Ltd. |
Active not recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07018453 |
Jul 2025 → Feb 2026 overdue |
type 2 diabetes mellitus |
Jiangsu HengRui Medicine Co., Ltd. |
Active not recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06688123 |
Jan 2025 → Apr 2026 |
type 2 diabetes mellitus |
Jiangsu HengRui Medicine Co., Ltd. |
Completed
|
No outcome recorded
|